4.4 Review

Roles of heterogenous hepatic macrophages in the progression of liver diseases

Journal

BMB REPORTS
Volume 55, Issue 4, Pages 166-174

Publisher

KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
DOI: 10.5483/BMBRep.2022.55.4.022

Keywords

Inflammation; Kupffer cells; Macrophage; Monocytes; NAFLD

Funding

  1. National Research Foundation of Korea (NRF) - Korea government (MSIT) [2021R1C1C1004023, 2021R1A4A3031661]
  2. National Research Foundation of Korea [2021R1C1C1004023, 2021R1A4A3031661] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Hepatic macrophages play a key role in liver diseases, including steatosis, inflammation, and fibrosis. Recent research has identified heterogenous populations of hepatic macrophages termed residential Kupffer cells and monocyte-derived macrophages, and their distinct population dynamics during the progression of various liver diseases. Understanding the functions of different subtypes of liver macrophages is critical in understanding liver pathology and identifying potential therapeutic targets.
Hepatic macrophages are key immune cells associated with the broad ranges of liver diseases including steatosis, inflammation and fibrosis. Hepatic macrophages interact with other immune cells and orchestrate hepatic immune circumstances. Recently, the heterogenous populations of hepatic macrophages have been discovered termed residential Kupffer cells and monocyte-derived macrophages, and identified their distinct population dynamics during the progression of various liver diseases. Liver injury lead to Kupffer cells activation with induction of inflammatory cytokines and chemokines, which triggers recruitment of inflammatory monocyte-derived macrophages. To understand liver pathology, the functions of different subtypes of liver macrophages should be regarded with different perspectives. In this review, we summarize recent advances in the roles of hepatic macrophages under liver damages and suggest hepatic macrophages as promising therapeutic targets for treating liver diseases. [BMB Reports 2022; 55(4): 166-174]

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available